US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      URAL ( 22V431000 )

      Dated: JUN 16, 2022 Irbit Motorworks of America, Inc. (Irbit) is recalling certain 2012-2017 Ural Gear Up, Ural Patrol (T), Ural Retro, 2012-2015 Ural … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / USRCN Editorial / Evidence is Mounting in Favor of an Avandia Recall

Evidence is Mounting in Favor of an Avandia Recall

November 7, 2008 By Austin Kirk 4 Comments

This is a guest editorial written by Maryland injury lawyer Austin Kirk, whose firm is investigating potential Avandia lawsuits for users throughout the United States. To speak with Mr. Kirk, call 1 (800) 522-0102

Avandia Alert – Click here for more information!

Over the past 18 months, a number of studies and reports have emerged which raise concerns about the safety of Avandia (rosiglitazone), and whether the drug should continue to remain on the market.

Last week, the consumer advocacy group Public Citizen filed a petition with the FDA asking the agency to issue an Avandia recall, indicating that the evidence against this once-popular type 2 diabetes drug is “overwhelming”.

The petition, which was filed on behalf of more than 80,000 consumers nationwide, called for an immediate Avandia ban as a result of “clear previous evidence of increased risk of heart attacks, heart failure, bone fractures, anemia and macular (retinal) edema with vision loss.”

Public Citizen also pointed to new evidence from an analysis they performed, which identified 14 cases of liver failure associated with Avandia, 12 of which resulted in death.

Health concerns surrounding the drug first emerged in May 2007, leading the FDA to issue an Avandia safety alert stating that studies show there is a “potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia.”

In November 2007, the FDA and GlaxoSmithKline announced that new language would be added to a ‘black box’ warning on the Avandia label about the potential heart attack risk. However, during the months leading up to this announcement, there was fierce internal debate within the FDA about whether to allow the drug to stay on the market. An FDA drug-safety oversight board narrowly voted against an Avandia recall 8 to 7.

In addition to the Public Citizen petition, there have been a series of developments over the past few months which make it appear likely that the FDA will revisit their decision about Avandia and consider withdrawing approval for the medication.

In August 2008, an editorial was published online by the medical journal Heart, in which researchers from Wake Forest University School of medicine questioned the rationale for leaving Avandia on the market, citing the serious side effects associated with the drug.

In addition, last month the American Diabetes Association and European Association for the Study of Diabetes dropped Avandia from their consensus statements on type 2 diabetes treatments, recommending against use of the drug.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: USRCN Editorial

Comments

  1. irma etchells says

    December 20, 2008 at 6:05 pm

    Is there any reimbursement for avandia if you had received it and in light of the recall not able to use the product?

    Reply
  2. Connie Dyson says

    May 13, 2010 at 1:09 pm

    I am suing the company that made Advandia.

    Reply

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

URAL ( 22V431000 )

June 25, 2022 By NHTSA

KENTUCKY TRAILER ( 22V419000 )

June 25, 2022 By NHTSA

KAUFMAN ( 22V421000 )

June 25, 2022 By NHTSA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

CRUISER RV ( 22V433000 )

June 24, 2022 By NHTSA

UTILIMASTER ( 22V417000 )

June 24, 2022 By NHTSA

HEARTLAND ( 22V432000 )

June 24, 2022 By NHTSA

TRIPLE E RV ( 22V435000 )

June 24, 2022 By NHTSA

Blount Fine Foods Voluntarily Recalls a Limited Amount (a Single Lot) of Southwest Corn Chowder Due to Undeclared Wheat Allergen

June 23, 2022 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

TRIPLE E RV ( 22V435000 )

June 24, 2022 By NHTSA

Blount Fine Foods Voluntarily Recalls a Limited Amount (a Single Lot) of Southwest Corn Chowder Due to Undeclared Wheat Allergen

June 23, 2022 By The FDA

Daily Harvest Issues Voluntary Recall of French Lentil + Leek Crumbles Due to Potential Health Risk

June 23, 2022 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • URAL ( 22V431000 )
  • KENTUCKY TRAILER ( 22V419000 )
  • KAUFMAN ( 22V421000 )
  • TOYOTA ( 22V444000 )
  • NOVA BUS ( 22V416000 )
  • CRUISER RV ( 22V433000 )
  • UTILIMASTER ( 22V417000 )
  • HEARTLAND ( 22V432000 )
  • TRIPLE E RV ( 22V435000 )
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2022 Altrumedia · Terms of Service · Log in